201 related articles for article (PubMed ID: 29565188)
1. Safety of cetirizine in pregnancy.
Golembesky A; Cooney M; Boev R; Schlit AF; Bentz JWG
J Obstet Gynaecol; 2018 Oct; 38(7):940-945. PubMed ID: 29565188
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.
Clowse ME; Wolf DC; Förger F; Cush JJ; Golembesky A; Shaughnessy L; De Cuyper D; Mahadevan U
J Rheumatol; 2015 Dec; 42(12):2270-8. PubMed ID: 26523031
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database.
Clowse MEB; Scheuerle AE; Chambers C; Afzali A; Kimball AB; Cush JJ; Cooney M; Shaughnessy L; Vanderkelen M; Förger F
Arthritis Rheumatol; 2018 Sep; 70(9):1399-1407. PubMed ID: 29623679
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.
Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J
Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431
[TBL] [Abstract][Full Text] [Related]
5. Prospective controlled study of hydroxyzine and cetirizine in pregnancy.
Einarson A; Bailey B; Jung G; Spizzirri D; Baillie M; Koren G
Ann Allergy Asthma Immunol; 1997 Feb; 78(2):183-6. PubMed ID: 9048526
[TBL] [Abstract][Full Text] [Related]
6. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy.
Namazy J; Cabana MD; Scheuerle AE; Thorp JM; Chen H; Carrigan G; Wang Y; Veith J; Andrews EB
J Allergy Clin Immunol; 2015 Feb; 135(2):407-12. PubMed ID: 25441639
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes following exposure to onabotulinumtoxinA.
Brin MF; Kirby RS; Slavotinek A; Miller-Messana MA; Parker L; Yushmanova I; Yang H
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):179-87. PubMed ID: 26635276
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir.
Vannappagari V; Thorne C;
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):371-378. PubMed ID: 30939532
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data.
Hoeltzenbein M; Beck E; Rajwanshi R; Gøtestam Skorpen C; Berber E; Schaefer C; Østensen M
Semin Arthritis Rheum; 2016 Oct; 46(2):238-245. PubMed ID: 27346577
[TBL] [Abstract][Full Text] [Related]
10. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
11. The fetal safety of cetirizine: an observational cohort study and meta-analysis.
Etwel F; Djokanovic N; Moretti ME; Boskovic R; Martinovic J; Koren G
J Obstet Gynaecol; 2014 Jul; 34(5):392-9. PubMed ID: 24678814
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.
Brin MF; Kirby RS; Slavotinek A; Adams AM; Parker L; Ukah A; Radulian L; Elmore MRP; Yedigarova L; Yushmanova I
Neurology; 2023 Jul; 101(2):e103-e113. PubMed ID: 37137724
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcomes after maternal use of thiocolchicoside: A case series.
Kaplan YC; Keskin-Arslan E; Küçüksolak G; Akyol F; Karadas B; Görgel SN; Kaya-Temiz T
Reprod Toxicol; 2018 Mar; 76():103-108. PubMed ID: 29378258
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide and pregnancy: Data from spontaneous and solicited reports.
Perucca P; Bourikas D; Voinescu PE; Vadlamudi L; Chellun D; Kumke T; Werhahn KJ; Schmitz B
Epilepsia; 2024 May; 65(5):1275-1284. PubMed ID: 38411300
[TBL] [Abstract][Full Text] [Related]
16. Ecotoxicity of the antihistaminic drug cetirizine to Ruditapes philippinarum clams.
Almeida Â; Calisto V; Esteves VI; Schneider RJ; Soares AMVM; Figueira E; Freitas R
Sci Total Environ; 2017 Dec; 601-602():793-801. PubMed ID: 28578237
[TBL] [Abstract][Full Text] [Related]
17. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
Cunnington M; Ephross S; Churchill P
Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
[TBL] [Abstract][Full Text] [Related]
18. Foetal and neonatal outcomes in first-trimester pregnant women exposed to abdominal or lumbar radiodiagnostic procedures without administration of radionucleotides.
Choi JS; Han JY; Ahn HK; Ryu HM; Kim MY; Chung JH; An GH; Nava-Ocampo AA
Intern Med J; 2013 May; 43(5):513-8. PubMed ID: 23181560
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
[TBL] [Abstract][Full Text] [Related]
20. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
